Joshua J. Neumiller, PharmD, CDCES, of the American Diabetes Association discusses pharmacists’ role in diabetes and CKD care from ASN Kidney Week 2026
|Videos|November 9, 2015
Why You Should Have a Travel Section in Your Pharmacy
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, talks about the benefits of having a travel section in a pharmacy.
Advertisement
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, talks about the benefits of having a travel section in a pharmacy.
This video was recorded at the 2015 NCPA Annual Convention.
Advertisement
Related to this article
Jai Radhakrishnan, MD, MBBS, MS, FASN, discusses why IgG4-related kidney disease is often missed and what the MITIGATE subgroup data presented at ASN Kidney Week 2026 show.
From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
Kidney Week 2026 posters show low-density lipoprotein cholesterol (LDL-C) fell by half in patients receiving dialysis, and oral enlicitide needed no dose adjustment for renal impairment.
Walgreens adds virtual coverage navigation, Medicare GLP-1 Bridge support, and pharmacist follow-up calls as GLP-1 discontinuation remains high.
A helpful guide for pharmacists if teas, supplements, or cultural foods are part of a patient's regular routine.
Real-world data from ASN Kidney Week show GLP-1 RA users with CKD and obesity had lower rates of kidney failure, death, and heart failure exacerbation.
Hiddo J. L. Heerspink, PharmD, PhD, discusses SOLSTICE elecoglipron data, finerenone in FSGS, and glucagon’s kidney effects from ASN Kidney Week 2026.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Walgreens Adds Pharmacist Outreach, Coverage Help for GLP-1s
2
Cystatin C and the Future of Kidney Function Assessment
3
GLP-1 RAs Tied to Lower Kidney Failure Risk in Patients With Obesity, CKD
4
The Growing Role the Specialty Pharmacy Team Plays in Helping Breast Cancer Patients Navigate Treatment
5